甲胎蛋白阴性肝细胞癌患者的预后分析
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

国家临床重点专科项目;江苏省实验诊断学重点实验室项目(ZDXKB 2016005)


Prognostic analysis of AFP⁃negative patients with hepatocellular carcinoma
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:分析探讨影响甲胎蛋白(alpha fetoprotein,AFP)阴性(AFP<20 ng/mL)肝细胞癌(hepatocellular carcinoma, HCC)患者术后生存的风险因素。方法:共纳入479例接受根治性切除的HCC患者。采用单因素和多因素Cox回归分析确定 AFP 阴性 HCC 的预后因素。Kaplan-Meier 法评估生存概率,并进行 Log-rank 检验。结果:年龄(HR=1.047,95% CI:1.002~ 1.094)、癌胚抗原(HR=1.151,95%CI:1.027~1.290)、糖类抗原 19-9(HR=1.053,95%CI:1.002~1.105)、天冬氨酸氨基转移酶 (HR=1.031,95%CI:1.001~1.070)及肿瘤大小(HR=1.289,95%CI:1.161~1.432)是AFP阴性HCC患者生存的独立风险因素。5个风险因素值的升高与AFP阴性HCC患者较差的预后相关,是影响总生存期(overall survival,OS)的危险因素(P< 0.05)。AFP 阴性HCC患者的OS明显长于AFP阳性HCC患者(P< 0.001)。结论:接受手术治疗的AFP阴性HCC患者,需要注意其肝功能和肿瘤指标的检测,特别是年龄超过65岁、肿瘤超过6 cm的患者。

    Abstract:

    Objective:The study aims to determine the risk factors affecting postoperative survival in patients with alpha-fetoprotein (AFP)negative(AFP<20 ng/mL)hepatocellular carcinoma(HCC). Methods:A total of 479 patients with HCC who underwent radical resection were recruited in the current study. Independent prognostic factors for AFP-negative HCC patients were determined using univariate and multifactorial Cox regression analysis. The Kaplan-Meier method was used to assess the probability of survival,and log- rank tests were performed. Results:Age(HR=1.047,95% CI:1.002-1.094),carcinoembryonic antigen(HR=1.151,95% CI:1.027- 1.290),carbohydrate antigen 19-9(HR=1.053,95% CI:1.002-1.105),aspartate aminotransferase(HR=1.031,95% CI:1.001-1.070) and tumor size(HR=1.289,95% CI:1.161- 1.432)were independent risk factors for survival in AFP-negative HCC patients. The elevated values of the 5 risk factors had negative impacts on prognosis and were independent risk factors for overall survival(OS)(P< 0.05). OS was longer in AFP-negative HCC patients than in AFP-positive HCC patients(P< 0.001). Conclusion:AFP-negative patients undergoing surgical treatment for HCC are required attention to liver function and tumor markers,especially in patients older than 65 years and with tumor size larger than 6 cm.

    参考文献
    相似文献
    引证文献
引用本文

卢英,雍景超,吴志奇.甲胎蛋白阴性肝细胞癌患者的预后分析[J].南京医科大学学报(自然科学版),2023,(11):1527-1534

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2023-05-29
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-11-17
  • 出版日期:
通知关闭
郑重声明